Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Not applicable

Effect of a Mobile App for Obese Children on Eating Attitudes, Eating Awareness, and Healthy Eating Self-Efficacy

NCT07289425 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-12-15
Last updated
2026-03-17

Condition(s) studied

ObesityChild Health

Investigational drug(s) / intervention(s)

Childhood Obesity Mobile Application

Childhood Obesity Mobile Application: With the support of computer engineers and software experts, the logo, user interface, overall appearance, and control panel will be designed to suit the purpose and subject matter of the mobile application. The mobile application will be designed to be used on both Android and iOS-based smartphones and in environments without internet access. After developing the prototype of the mobile application, its usability will be tested. In this context, the testing process will first be carried out by researchers. Academic nurses (n=3) and outpatient clinic nurses (n=2) will evaluate the application using the Mobile Application Usability Scale. If any problems are identified in the application, they will be resolved and the necessary adjustments will be made.

Study summary

This study aims to evaluate the effect of a mobile application developed for obese children on eating attitudes, eating awareness, and healthy eating self-efficacy. The application seeks to support children in developing healthy eating habits and to integrate nursing interventions with digital health technologies in combating obesity. Data will be collected through a researcher-developed Information Form and three validated scales: the Eating Attitude Test, the Eating Awareness Scale, and the Healthy Eating Self-Efficacy Scale, completed by both children and parents.

Eligibility

Sex
ALL
Min age
8 Years
Max age
10 Years
Healthy volunteers
No
Inclusion Criteria: * The child must be between 8 and 10 years old, * The child must not have any chronic illnesses other than obesity, * The child must be able to read and write in Turkish, * The child must be able to use a mobile device, * The child must not have a visual impairment, * The parent must be willing to participate in the study, * The parent must be able to read and write in Turkish, * The parent or child must have a smartphone. Exclusion Criteria: * If they wish to withdraw from the study at any stage of the research, * If they do not wish to use the mobile application at any stage of the research.

Primary outcome measure(s)

  • Eating Attitude Test for Children — At baseline, 4 weeks after the start of the intervention, and 8 weeks after the start of the intervention
    This scale is used to identify eating-related attitudes and behaviors among children aged 8-15. It consists of 26 items and evaluates general patterns indicating how children feel, think, and behave regarding eating, using a six-point Likert-type structure.
  • Eating Awareness Scale for Children — At baseline, 4 weeks after the start of the intervention, and 8 weeks after the start of the intervention
    This scale assesses the level of attention children aged 8-11 pay to food during eating behaviors and evaluates inattentive or automatic eating tendencies through its 12-item, two-dimension structure, using a four-point Likert-type format.

Trial sites (1)

FacilityCityRegionStatus
Sivas Cumhuriyet University Sivas Merkez
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07289425 on ClinicalTrials.gov ↗ ← All trials in Turkey